Disease modelling using pluripotent stem cells: Making sense of disease from bench to bedside

Swiss Medical Weekly

Volumn 141, Issue FEBRUARY, 2011, Pages

  Saha, Krishanu ^a   Hurlbut, J Benjamin ^b  

^a HARVARD UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Disease modelling; Ethics; iPS cells; Reprogramming; Science policy; Stem cells

Indexed keywords

BIOETHICS; CELL LINE; CELL THERAPY; CLINICAL RESEARCH; DISEASE IN A DISH MODEL; DISEASE MODEL; DONOR; HUMAN; LABORATORY; MEDICAL TECHNOLOGY; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; RESEARCH SUBJECT; REVIEW; BIOENGINEERING; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CLINICAL MEDICINE; CULTURE TECHNIQUE; CYTOLOGY; ETHICS; PATIENT PARTICIPATION;

BIOENGINEERING; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CLINICAL MEDICINE; HUMANS; MODELS, BIOLOGICAL; PATIENT PARTICIPATION; PLURIPOTENT STEM CELLS;

EID: 79955905511     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2011.13144     Document Type: Review

References (29)

1. Daley GQ, Scadden DT. Prospects for stem cell-based therapy. Cell. 2008;132(4):544-8. (Pubitemid 351253699)
2. Saha K, Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell. 2009;5(6):584-95.
3. Rossant J. Stem cells and early lineage development. Cell. 2008;132(4):527-31. (Pubitemid 351253691)
4. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-76. (Pubitemid 44233629)
5. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, et al. Disease-specific induced pluripotent stem cells. Cell. 2008;134(5):877-86.
6. Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang Y-S, Schaniel C, Lee D-F, et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature. 2010;10;465(7299):808-12.
7. Johnson C. Stem cells allow drug trials in a dish. South San Francisco, CA: KGO-TV; 2009.
8. CIRM. Stem Cells Accelerating Basic Research. Available from: http://www.cirm.ca.gov/StemCellBasics-BasicResearch.
9. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467(7313):285-90.
10. Hanna JH, Saha K, Jaenisch R. Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues. Cell 2010;143(4):508-25. doi:10.1016/j.cell.2010.10.008.
11. Caulfield T, Scott C, Hyun I, Lovell-Badge R, Kato K, Zarzeczny A. Stem cell research policy and iPS cells. Nat Methods. 2010;7(1):28-33.
12. Simon BM, Murdoch CE, Scott CT. Pluripotent patents make prime time: an analysis of the emerging landscape. Nature Biotechnology. 2010;28(6):557-9.
13. Zarzeczny A, Scott C, Hyun I, Bennett J, Chandler J, Chargé S, et al. iPS cells: mapping the policy issues. Cell. 2009;139(6):1032-7.
14. Hippocrates. Of The Epidemics: Kessinger Publishing; 2004.
15. Kleinman A. The illness narratives: suffering, healing, and the human condition: Basic Books; 1989.
16. Rosenberg CE. The tyranny of diagnosis: specific entities and individual experience. The Milbank Quarterly 2002;80(2):237-60.
17. Hacking I. The social construction of what?: Harvard University Press; 1999.
18. Epstein S. Impure Science: AIDS, Activism, and the Politics of Knowledge: University of CaliforniaPress; 1996.
19. Epstein S. Inclusion: The Politics of Difference in Medical Research: University Of Chicago Press; 2009.
20. Feudtner JC. Bittersweet: diabetes, insulin, and the transformation of illness: UNC Press; 2003.
21. Marks HM. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990: Cambridge University Press; 2000.
22. Weisz G. Divide and Conquer: A Comparative History of Medical Specialization: Oxford University Press, USA; 2005.
23. Rosenberg CE. Framing Disease: Studies in Cultural History: Rutgers University Press; 1992.
24. Foucault M. The Birth of the Clinic: An Archaeology of Medical Perception: Vintage; 1994.
25. Jewson ND. The Disappearance of the Sick-Man from Medical Cosmology, 1770-1870. Sociology. 1976;10(2):225-44.
26. Ackerknecht EH. Medicine at the Paris Hospital, 1794-1848. Baltimore: Johns Hopkins Press; 1967.
27. Albury WR. Corvisart and Broussais: Human Individuality and Medical Dominance. Constructing Paris Medicine. Amsterdam: Editions Rodopi B. V.; 1998. p. 221-50.
28. Weisz G. The Medical Mandarins: the French Academy of Medicine in the nineteenth and early twentieth centuries: Oxford University Press US; 1995.
29. Callon M, Rabeharisoa V. The Growing Engagement of Emergent Concerned Groups in Political and Economic Life: Lessons from the French Association of Neuromuscular Disease Patients. Science, Technology & Human Values. 2008;33(2):230-261.